Basic Information
An early focus of Numa Biosciences is leveraging data generated from a wide range of advanced in vitro models, particularly human microphysiological systems (MPS), as well as animal models and clinical data, for workflows ranging from early drug discovery and development to "preclinical trials."
Numa Biosciences, Inc.
Pittsburgh,Pennsylvania,United States of America
51~100 people
June 26, 2023
--
--

